Sign In
Buy JAZZ
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
A Week's Worth of Actionable Cannabis Stock News
08:14am, Monday, 16'th Aug 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape
Jazz's (JAZZ) Xywav Gets FDA Nod for Idiopathic Hypersomnia
10:52am, Friday, 13'th Aug 2021
Jazz's (JAZZ) Xywav gets FDA approval for new indication, idiopathic hypersomnia. Following approval, Xywav becomes the first drug for treatment of this sleep disorder.
DUBLIN, Aug. 12, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved Xywav® (calcium, magnesium, potassium, and sod
Jazz's (JAZZ) Epidyolex Gets Approval for New Indication in UK
02:50pm, Wednesday, 11'th Aug 2021
Jazz's (JAZZ) unit GW Pharmaceuticals' Epidyolex (cannabidiol) gets a regulatory nod for a new indication in the United Kingdom. Following this announcement, stock prices fell.
Stand Up To Cancer And Jazz Pharmaceuticals Collaborate To Fund Catalyst Research On Hard-To-Treat Cancers
08:00am, Tuesday, 10'th Aug 2021
LOS ANGELES, Aug. 10, 2021 /PRNewswire/ -- Stand Up To Cancer® (SU2C) and Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announce a three-year, $4 million research collaboration to explore new opportu
LONDON, Aug. 10, 2021 /PRNewswire/ -- GW Pharmaceuticals ("GW"), a world leader in discovering, developing and delivering regulatory approved cannabis-based medicines and now part of Jazz Pharmaceutic
Your Weekly Hit of Cannabis Stocks on the Move
02:51pm, Friday, 06'th Aug 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape
Jazz Pharma (JAZZ) Q2 Earnings Beat, Sales Ride on GW Buyout
12:13pm, Wednesday, 04'th Aug 2021
Jazz Pharma's (JAZZ) product revenues grow in the second quarter on the back of strong demand for its new drugs and additional sales from drugs added with the acquisition of GW Pharmaceuticals.
Jazz Pharmaceuticals' (JAZZ) CEO Bruce Cozadd on Q2 2021 Results - Earnings Call Transcript
09:34pm, Tuesday, 03'rd Aug 2021
Jazz Pharmaceuticals' (JAZZ) CEO Bruce Cozadd on Q2 2021 Results - Earnings Call Transcript
Jazz Pharmaceuticals (JAZZ) Tops Q2 Earnings and Revenue Estimates
08:35pm, Tuesday, 03'rd Aug 2021
Jazz (JAZZ) delivered earnings and revenue surprises of 9.86% and 1.16%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Jazz Pharmaceuticals Q2 Earnings
05:33pm, Tuesday, 03'rd Aug 2021
Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 5.12% over the past year to $3.90, which
Jazz Pharmaceuticals's Earnings: A Preview
10:59am, Monday, 02'nd Aug 2021
Jazz Pharmaceuticals (NASDAQ:JAZZ) releases its next round of earnings this Tuesday, August 03. Get the latest predictions in Benzinga's essential guide to the company's Q2 earnings report.
Onera raises €10.5M in Series B funding
04:00am, Thursday, 29'th Jul 2021
EINDHOVEN, Netherlands--(BUSINESS WIRE)--Onera Health, a leader in sleep diagnostic and monitoring solutions, closed the Series B funding round today, which brought the total funding raised to date ab
Is Jazz Pharmaceuticals Stock a Buy?
06:19am, Saturday, 24'th Jul 2021
Jazz Pharma is not the most popular drugmaker, but it is definitely worth a second look.
DUBLIN, July 22, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the National Comprehensive Cancer Network® (NCCN) added Rylaze™ (asparaginase erwinia chrysanthem
